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Adverse events are common among surgical patients. The 
question of how to predict risk associated with invasive 
procedures and how to select an optimal procedure for 
particular patients is as old as surgery itself. Accurate 
calculation of complication risk and mortality risk has three 
important aspects:
(I) Risk assessment and its discussion with a patient 
is essential for their informed consent to undergo 
surgery;
(II) Determination of risk allows for implementation of 
specific measures, aimed at reduction of this risk;
(III) Awareness of the adverse event that is likely to 
happen enables one to get prepared for it, to 
provide optimal setting for the procedure and to 
use appropriate treatment without delay.
Numerous risk factors for different adverse events have 
been described and surgeons are well familiar with them. 
However, precise calculation of risk in the actual patient is 
not a simple task. This is because the multifactorial nature 
of complications’ aetiology, and very complex interplay 
between these factors and intrinsic patient’s characteristics. 
Also, for reliable statistical analysis, reliable data are 
necessary.
Development of appropriate databases is extremely 
difficult, time-consuming and an expensive task. Ideally, 
such a database should include prospectively collected 
sets of relevant data, collected in a non-selective way in a 
large cohort of patients operated on over a relatively short 
period of time. In fact, this means multi-institutional and 
even international projects, run by highly professional 
teams including surgeons, IT specialists and statisticians, 
supported by a large number of high-volume institutions 
providing patients’ data.
There is no doubt that such an ideal database does not 
exist, due to the abovementioned inherent problems. There 
are, however, databases, which were used to produce risk 
models that are successfully used by thoracic surgeons 
worldwide. The first of them is the Thoracoscore, derived 
from the national French database, Epithor (1). The second 
to be mention is the database of the Society of Thoracic 
Surgeons (2). The most recent attempt to create improved 
risk model was presented during the conference of the 
European Society of Thoracic Surgeons (ESTS) in Naples 
in 2016, and published thereafter in the European Journal 
of Cardiothoracic Surgery (3).
This latter risk model is particularly promising because 
the ESTS database meets several of the criteria of an 
ideal surgical database: it is collected prospectively, using 
uniform, web-based tool, it contains most of the important 
clinical information and includes data from multiple 
institutions collected in a short period of time. The authors 
used data of 47,960 patients operated on between 2007 and 
2015. Using advanced statistical methods, they developed 
two risk models: for morbidity (EuroLung1) and mortality 
(EuroLung2).
The bootstrap method, introduced in the1970s by Efron, 
is becoming more and more popular due to availability 
of computers of high computing power and sophisticated 
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software (4). It is generally based on creation of artificial 
population by resampling of the original, finite sample.
Brunelli et al. have used 8 variables to create the 
EuroLung1 and 9 variables for EuroLung2. The variables 
found to be associated with morbidity after logistic regression 
analysis include: gender, age, predicted postoperative FEV1, 
coronary artery disease, cerebrovascular disease, renal 
failure, thoracotomy approach and extended resections. The 
aggregate EuroLung1 stratifies the patients into 6 categories 
of incremental risk of complications. On the other hand, 
the variables found to be associated with mortality after 
logistic regression analysis included: gender, age, predicted 
postoperative FEV1, coronary artery disease, cerebrovascular 
disease, BMI, thoracotomy approach, pneumonectomy 
and extended resections. The aggregate EuroLung2 score 
stratifies patients into 6 categories of incremental risk of 
mortality.
The new risk models have some limitations. Firstly, the 
ESTS database does not include all pulmonary resections. 
Approximately 20% of European thoracic surgical 
departments contribute to the database. Moreover, as 
contribution is voluntary, there is a bias due to a larger 
representation of high-volume, university-based centres. 
Some data, like DLCO or VOmax were available for a 
minority of patients and were therefore not included in the 
final analysis. Mortality was reported for the 30-day period, 
so the 90-day mortality in unknown. Also, the category 
‘thoracotomy approach’ that found a risk factor for both, 
morbidity and mortality, does not differentiate between 
large postero-lateral approach and the muscle-sparing 
mini-thoracotomy; this is likely to be the reason for bias 
regarding this parameter.
Nevertheless, the EuroLung1 and EuroLung2 models 
are probably the most reliable risk models available 
today. They present important progress in our struggle 
to preoperatively define surgical risk and, therefore, to 
improve results of treatment of patients with lung cancer.
Regrettably, there is no web-based, simple calculator 
available, that could be used to calculate the EuroLung1 
and EuroLung2 scores, as it was done for the Thoracoscore. 
Let us hope that such calculator will appear soon on the 
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